ALC - CIK 0001167379
ALCON INC trades as ALC and has a market capitalization of $32.36 B, making it the #441 largest US-listed company by market value. This page tracks ALCON INC through 526 SEC filings, with financial statements and metrics updated as new reports are filed.
| Filing | Type | Filed |
|---|---|---|
| SD | - | 2026-05-15 |
| 6-K | - | 2026-05-05 |
| 6-K | - | 2026-04-02 |
| Insider sale notice | 144 | 2026-02-26 |
| Insider sale notice | 144 | 2026-02-26 |
| 6-K | - | 2026-02-24 |
| 20-F | - | 2026-02-24 |
| 6-K | - | 2026-02-24 |
**First-quarter 2026 sales of $2.7 billion, up 10%** **on a reported basis, or up 6% constant currency1 (cc), versus first-quarter 2025**
**Shareholders approve all agenda items presented**
**TruPlus is designed to increase depth of focus while maintaining the high-quality distance vision surgeons expect from a monofocal IOL1,2**
Alcon Publishes Agenda for 2026 Annual General Meeting
Alcon and LENSAR, Inc. Agree to Terminate Merger Agreement
The largest companies sharing ALCON INC's SEC industry classification (ophthalmic goods).
ALCON INC (ALC) has a market capitalization of $32.36 B as of 2026-06-11, ranking #441 among US-listed companies.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.